Health Action International Applauds Medicines Patent Pool, ViiV Healthcare Licensing Agreement for New HIV Treatment

Health Action International congratulates the Medicines Patent Pool (MPP) and ViiV Healthcare—a joint venture between GlaxoSmithKline, Pfizer and Shionogi—for signing two new licensing agreements for the production of the promising HIV treatment, dolutegravir. The agreement will enable generic competition for the drug to occur in a wide range of countries.

Read more…

START TYPING AND PRESS ENTER TO SEARCH